Study for the assessment of clinical non-inferiority and tolerability of Estrogenon (Sanval Comercio e Industria Ltda) in comparasion to Premarin (Wyeth Industria Farmaceutica Ltda) in women post menopause.

Phase 3

• Conditions: Study with the purpose of check clinical non- inferiority and tolerance of conjugated estrogen coated tablet manufactured by different manufactures; Reproductive Health and Childbirth - Menstruation and menopause; Women in post menopause with indications for estrogens replacement therapy.

• Registration Number: ACTRN12610000119099
• Lead Sponsor: Sanval Comercio e Industria Ltda

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-02-04
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 66

Inclusion Criteria

Women in menopause with indications for estrogen replacement therapy.

Exclusion Criteria

Patients with contraindications for estrogen use.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Endometium thickness; alterations in clinical examination (gynecological)[at 90 days from baseline.]

Secondary Outcome Measures

Name	Time	Method
il[Nil]